ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Review of the 2017 Document for the Cardiac Anesthesiologist.

Carpentier classification chronic primary mitral regurgitation chronic secondary mitral regurgitation expert consensus decision pathway guidelines for management of valvular regurgitation mitral valve repair mitral valve replacement transesophageal echocardiography

Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
02 2019
Historique:
received: 20 01 2018
pubmed: 29 8 2018
medline: 4 4 2019
entrez: 29 8 2018
Statut: ppublish

Résumé

Chronic mitral regurgitation (MR) is the most prevalent valvular lesion in the adult US population. Appropriate patient selection for mitral intervention and selection of the appropriate interventional strategy and optimal periprocedural management rely on thorough clinical evaluation, accurate echocardiographic input, and in-depth understanding of chronic MR pathophysiology on the part of the cardiac anesthesiologist. The recently published Expert Consensus Decision Pathway on the management of MR was designed to provide tools to help the clinician with broad clinical decision-making, including patient referral, and the present review focuses and elaborates on the key aspects relevant to the cardiac anesthesiologist in the peri-interventional setting.

Identifiants

pubmed: 30149983
pii: S1053-0770(18)30530-5
doi: 10.1053/j.jvca.2018.07.029
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-289

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Pankaj Jain (P)

Miller School of Medicine, University of Miami, Miami, FL. Electronic address: pxj134@med.miami.edu.

Michael Fabbro (M)

Miller School of Medicine, University of Miami, Miami, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH